It is a chemicals private limited company based in Na, Telangana, India, established in 1997.
1997 | Na, Telangana, India | Struck OffHalmak Pharmaceuticals Private Limited, a struck off private limited company, was established on 13 February 1997 in Na, Telangana, India. Engaging in medicinal chemical & botanical products within the manufacturing sector, it holds CIN: U24230TG1997PTC026415. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.12 M.
Its leadership includes Puram Ramakrishna (Director), Kadhthamar Manjunatha Shetty Shekhar (Director), Balasubramaniam (Director). Past directors included Puram Ramakrishna, Kadhthamar Manjunatha Shetty Shekhar, Sujeethreddy Suguru. Its latest AGM occurred on 30 September 2015, with the balance sheet filed on 31 March 2015. It is based at Flat No.30 Shiv Baghsharam Karan Road,Ameerpet, Hyderabad, Na, Telangana.
U24230TG1997PTC026415
026415
13 February 1997
₹1.00 M
₹0.12 M
Roc Hyderabad
Unlisted
Struck Off
Explore comprehensive insights into Halmak Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Puram Ramakrishna | Director | 17 Dec 2014 | Current |
| Kadhthamar Manjunatha Shetty Shekhar | Director | 17 Dec 2014 | Current |
| Balasubramaniam | Director | 17 Dec 2014 | Current |
| Vankadara Srinivasulu | Managing Director | 13 Feb 1997 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2015 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2015 | Past |
| Pramod Abcsdd | Additional Director | 27 Oct 2015 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2015 | Past |
| Pramod Abcsdd | Director | 18 Dec 2014 | Past |
| Pramod Abcsdd | Director | 18 Dec 2014 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Halmak Pharmaceuticals Private Limited, for the financial year ended 2015, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2015, Halmak Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Halmak Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Halmak Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Halmak Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Halmak Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2015 as per latest MCA records. was documented.
The activity Halmak Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2015 with Roc Hyderabad. was completed.
Puram Ramakrishna was appointed as a Director was appointed as a Director on 17 Dec 2014 & has been associated with this company since 11 years 4 days . was recorded as a recent event.
Kadhthamar Manjunatha Shetty Shekhar was appointed as a Director was appointed as a Director on 17 Dec 2014 & has been associated with this company since 11 years 4 days . was recorded as a recent event.
Balasubramaniam was appointed as a Director was appointed as a Director on 17 Dec 2014 & has been associated with this company since 11 years 4 days . was recorded as a recent event.
Progress on Vankadara Srinivasulu was appointed as a Managing Director was appointed as a Managing Director on 13 Feb 1997 & has been associated with this company since 28 years 10 months . was documented.
The CIN of Halmak Pharmaceuticals Private Limited is U24230TG1997PTC026415.
Halmak Pharmaceuticals Private Limited is headquartered at Flat No.30 Shiv Baghsharam Karan Road,Ameerpet, Hyderabad, Na, Telangana.
Halmak Pharmaceuticals Private Limited was incorporated on 13 February 1997.
The current directors of Halmak Pharmaceuticals Private Limited are
The primary industry of Halmak Pharmaceuticals Private Limited is Manufacturing.
Halmak Pharmaceuticals Private Limited is unlisted.
The authorized capital of Halmak Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.12 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX